CMAJ November 4, 2008; 179 (10). doi:10.1503/cmaj.081103.
© 2008 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia
David B. Hogan, MD,
Peter Bailey, MD,
Sandra Black, MD,
Anne Carswell, MSc PhD,
Howard Chertkow, MD,
Barry Clarke, MD,
Carole Cohen, BA MD,
John D. Fisk, PhD,
Dorothy Forbes, RN PhD,
Malcolm Man-Son-Hing, MSc MD,
Krista Lanctôt, PhD,
Debra Morgan, RN PhD and
Lilian Thorpe, MD PhD
From the Departments of Medicine and Clinical Neurosciences (Hogan), University of Calgary, Calgary, Alta.; the Division of Neurology, Department of Medicine (Bailey), the School of Occupational Therapy (Carswell), the Department of Family Medicine (Clarke) and the Department of Psychiatry (Fisk), Dalhousie University, Halifax, NS; the Department of Medicine (Black), Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ont.; the School of Nursing (Forbes), Faculty of Health Sciences, University of Western Ontario, London, Ont.; the Department of Neurology and Neurosurgery (Chertkow), McGill University, Montréal, Que.; the Departments of Psychiatry (Cohen, Lanctôt) and Pharmacology (Lanctôt), University of Toronto, Toronto, Ont.; the Department of Medicine (Man-Son-Hing), University of Ottawa, Ottawa, Ont.; and the Canadian Centre for Health and Safety in Agriculture (Morgan) and the Department of Psychiatry (Thorpe), University of Saskatchewan, Saskatoon, Sask.